Literature DB >> 24285238

Alternative synthesis for the preparation of 16α-[(18) F]fluoroestradiol.

Hee Seup Kil1, Han Yang Cho, Sang Ju Lee, Seung Jun Oh, Dae Yoon Chi.   

Abstract

We have developed a new precursor, 3,17β-O-bis(methoxymethyl)-16β-O-p-nitrobenzenesulfonylestriol (14c) of 16α-[(18) F]fluoroestradiol ([(18) F]FES). Although we could not selectively protect the C17 alcohol in the presence of the C16 alcohol, we were able to prepare and chromatographically isolate the desired C16 TBDMS, C17,C3-dimethoxymethyl (diMOM) protected estriol derivative and convert into the ultimate fluorination precursor. The MOM protective group proved to be more quickly removed than the cyclic sulfate group. The di-MOM protective precursor at the C3 and C17 alcohols instead of a cyclic sulfate group shortened hydrolysis time. We prepared three different sulfonate precursors at C16 alcohol. After checking their reactivity in the [(18) F]fluorination step and considering the stability of the precursors, we obtained the best results with nosylate precursor 14c.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  16α-[18F]Fluoroestradiol; PET; [18F]FES; imaging of estrogen receptor; radiopharmaceutical

Mesh:

Substances:

Year:  2013        PMID: 24285238     DOI: 10.1002/jlcr.3076

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  4 in total

1.  Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.

Authors:  Dong Zhou; Mai Lin; Norio Yasui; Mohammed H Al-Qahtani; Carmen S Dence; Sally Schwarz; John A Katzenellenbogen
Journal:  J Labelled Comp Radiopharm       Date:  2014-02-17       Impact factor: 1.921

2.  Ring opening of epoxides with [18F]FeF species to produce [18F]fluorohydrin PET imaging agents.

Authors:  Stefan Verhoog; Allen F Brooks; Wade P Winton; Benjamin L Viglianti; Melanie S Sanford; Peter J H Scott
Journal:  Chem Commun (Camb)       Date:  2019-05-30       Impact factor: 6.222

Review 3.  PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.

Authors:  John A Katzenellenbogen
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

Review 4.  The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Authors:  John A Katzenellenbogen
Journal:  Nucl Med Biol       Date:  2020-02-22       Impact factor: 2.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.